LAKISHA SWINDELL-GLENN: Open Payments
NPI 1811404122 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,239 in 92 payments from 19 companies in 2025. Trend: 2023 $1,573 · 2024 $3,634 · 2025 $2,239
Food & beverage: $2,239
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 18 | $525 |
| ABBVIE INC. | 12 | $269 |
| Endo USA, Inc. | 7 | $260 |
| Astellas Pharma US Inc | 7 | $156 |
| Janssen Biotech, Inc. | 6 | $153 |
| PFIZER INC. | 7 | $152 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $121 |
| COLOPLAST CORP | 6 | $107 |
| UROGEN PHARMA, INC. | 4 | $93 |
| Blue Earth Diagnostics | 3 | $58 |
Products named: GEMTESA, XTANDI, BOTOX, XIAFLEX, ORGOVYX, ERLEADA, Nubeqa, AVEED.
Industry payments across VA — which companies pay providers there.
